ADME-Guided Design and Synthesis of Aryloxanyl Pyrazolone Derivatives To Block Mutant Superoxide Dismutase 1 (SOD1) Cytotoxicity and Protein Aggregation: Potential Application for the Treatment of Amyotrophic Lateral Sclerosis

MLA

Richard B. Silverman, et al. “ADME-Guided Design and Synthesis of Aryloxanyl Pyrazolone Derivatives To Block Mutant Superoxide Dismutase 1 (SOD1) Cytotoxicity and Protein Aggregation: Potential Application for the Treatment of Amyotrophic Lateral Sclerosis.” Journal of Medicinal Chemistry, vol. 55, Dec. 2011, pp. 515–27. EBSCOhost, https://doi.org/10.1021/jm2014277.

APA

Richard B. Silverman, Radhia Benmohamed, Richard I. Morimoto, Jinho Kim, Robert J. Ferrante, Daniel J. Amante, Karen M. Smith, Tian Chen, & Donald R. Kirsch. (2011). ADME-Guided Design and Synthesis of Aryloxanyl Pyrazolone Derivatives To Block Mutant Superoxide Dismutase 1 (SOD1) Cytotoxicity and Protein Aggregation: Potential Application for the Treatment of Amyotrophic Lateral Sclerosis. Journal of Medicinal Chemistry, 55, 515–527. https://doi.org/10.1021/jm2014277

Chicago

Richard B. Silverman, Radhia Benmohamed, Richard I. Morimoto, Jinho Kim, Robert J. Ferrante, Daniel J. Amante, Karen M. Smith, Tian Chen, and Donald R. Kirsch. 2011. “ADME-Guided Design and Synthesis of Aryloxanyl Pyrazolone Derivatives To Block Mutant Superoxide Dismutase 1 (SOD1) Cytotoxicity and Protein Aggregation: Potential Application for the Treatment of Amyotrophic Lateral Sclerosis.” Journal of Medicinal Chemistry 55 (December): 515–27. doi:10.1021/jm2014277.